Search results
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 1 month agoVertex Pharmaceuticals (NASDAQ: VRTX) is a growing pharmaceutical company with a robust cystic fibrosis (CF) business that generated nearly $10 billion...
Stock-Split Watch: Is Vertex Pharmaceuticals Next?
Motley Fool via Yahoo Finance· 3 months agoCompanies perform stock splits for a variety of reasons, from a desire to increase the liquidity of their shares to an interest in making them more...
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know
Zacks via Yahoo Finance· 1 month agoThe most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $394.17,...
Vertex Pharmaceuticals (VRTX) Stock Moves -0.1%: What You Should Know
Zacks via Yahoo Finance· 8 months agoVertex Pharmaceuticals (VRTX) closed at $343.96 in the latest trading session, marking a -0.1% move...
Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) Stock Has Fared Decently: Is the Market...
Simply Wall St. via Yahoo Finance· 1 year agoVertex Pharmaceuticals' (NASDAQ:VRTX) stock is up by 9.4% over the past three months. Since the...
Is Vertex Pharmaceuticals Stock a Buy Now?
Motley Fool via Yahoo Finance· 3 months agoVertex Pharmaceuticals (NASDAQ: VRTX) has been one of the hottest growth stocks to own within the healthcare industry. The company has a dominant cystic...
Vertex Pharmaceuticals Stock: Bear vs. Bull
Motley Fool· 11 months agoVertex Pharmaceuticals (NASDAQ: VRTX) is heading toward a big moment: a regulatory decision on what may become its next game-changing product. Investors...
IBD 50 Stocks To Watch: Vertex Pharmaceuticals In Buy Zone As Firm Gets On A Roll
Investor's Business Daily· 1 year agoBiotech stock Vertex Pharmaceuticals is in the buy zone of a base. Vertex stock is Tuesday's IBD 50...
Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now?
Zacks via Yahoo Finance· 2 years agoVertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
